Shatavari

<h3> Absolute Contraindications of Shatavari </h3> <h4>Pregnancy - Avoid or use only under supervision</h4> <ul> <li> 🤰 <li> Recommendation: Do not take Shatavari during pregnancy unless under close medical supervision; discuss with your obstetrician first. <li> Reasoning: Animal experiments (maternal exposure to concentrated root extracts) showed fetal resorptions, growth retardation and developmental delays in offspring; while human data are limited, animal teratogenic signals are a valid reason for caution. <li> Scientific_Study_Title: Teratogenicity of Asparagus racemosus Willd. root, a herbal medicine <li> Scientific_Study_Authors: R K Goel, T Prabha, M Mohan Kumar, M Dorababu, Prakash, G Singh <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16872047/ <li> Scientific_Study_Excerpt: <p>In a controlled animal study (Charles Foster rats), mothers given methanolic root extract (100 mg/kg/day for 60 days) showed increased fetal resorption, gross malformations (including limb swelling), intrauterine growth restriction and smaller placental size. Pups exposed in utero had lower body weight and delays in developmental parameters compared with controls. The authors concluded that exposure to concentrated Asparagus racemosus root extract during gestation produced teratological effects in this model and therefore advised caution when using the herb during pregnancy.</p> <p>The study is an animal teratogenicity report; direct human data are limited, but these findings form the basis for conservative clinical guidance to avoid routine use in pregnancy without specialist oversight.</p> </ul> <h4>Known allergy to asparagus / related plants [Onion/leek/garlic family sensitivity]</h4> <ul> <li> ⚠️ (allergy) <li> Recommendation: If you have known food or pollen allergies to asparagus, onions, leeks, garlic or related plants - avoid Shatavari or test under medical supervision (skin testing or supervised oral challenge by an allergist). <li> Reasoning: Reported IgE-mediated and contact allergic reactions to asparagus and related Liliaceae/Asparagales members exist; sensitized individuals can experience inhalant or ingestion reactions, including conjunctivitis, rhinitis, cough or more severe responses. <li> Scientific_Study_Title: Inhalant allergy to fresh asparagus <li> Scientific_Study_Authors: P A Eng, L Yman, E Maaninen, B Wüthrich <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8729671/ <li> Scientific_Study_Excerpt: <p>Two case reports described patients who developed itching conjunctivitis, nasal discharge, throat tightness and cough during handling/preparation of fresh asparagus; cooked asparagus did not provoke symptoms. Both patients had measurable asparagus-specific IgE and positive skin-prick tests to native asparagus. The study documents that asparagus can be a specific inhalant/food allergen in sensitized individuals and that reactions can be immediate and IgE mediated.</p> <p>Clinically this supports avoiding Asparagus racemosus products (especially powdered or raw forms that can aerosolize) if there is known hypersensitivity to asparagus or closely related plant allergens.</p> </ul> <h4>History of severe hypersensitivity/anaphylaxis to Asparagus products</h4> <ul> <li> 🚨 <li> Recommendation: Do not use Shatavari if you have previously had severe allergic reactions or anaphylaxis to asparagus or supplements containing it. <li> Reasoning: Case reports and reviews document IgE-mediated and occupational contact reactions to asparagus; prior anaphylaxis to the same botanical predicts high risk on re-exposure. <li> Scientific_Study_Title: [Review] Allergy to asparagus <li> Scientific_Study_Authors: (authors grouped in PubMed review) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/13679959/ <li> Scientific_Study_Excerpt: <p>Reviews and clinical reports summarize that asparagus can trigger IgE-mediated food allergy, contact urticaria and respiratory symptoms, particularly in occupational exposures. Both immediate IgE responses and delayed cell-mediated reactions have been described; identification and avoidance remain the mainstays of management. These reports emphasize that people with documented severe reactions should avoid re-exposure to asparagus preparations.</p> </ul> <h3> Relative Contraindications of Shatavari </h3> <h4>Concurrent Lithium therapy</h4> <ul> <li> 💊 <li> Recommendation: Consult your prescribing clinician before using Shatavari if you take lithium - avoid unsupervised use; monitoring of lithium levels may be required if both are used. <li> Reasoning: Herbal monographs and drug interaction resources note that Asparagus racemosus may have mild diuretic-like effects which can reduce renal lithium clearance and raise lithium levels, increasing risk of lithium toxicity; controlled human pharmacokinetic studies are lacking. <li> Scientific_Study_Title: Asparagus racemosus: monograph (interaction summary) <li> Scientific_Study_Authors: Web monograph (Therapeutic Research Center / WebMD content editors) <li> Scientific_Study_Link: https://www.webmd.com/vitamins/ai/ingredientmono-1167/asparagus-racemosus <li> Scientific_Study_Excerpt: <p>Herbal reference monographs report a potential interaction between Asparagus racemosus and lithium based on the herb's possible mild diuretic activity; because lithium is renally cleared, substances that alter fluid or electrolyte balance may increase lithium levels. Direct controlled clinical trials are not available on PubMed, so the interaction is listed as possible/precautionary based on pharmacologic reasoning and case-based caution in compendia. Clinicians generally advise caution and monitoring of lithium concentrations if patients elect to use such herbs concurrently.</p> </ul> <h4>Use with potent estrogen / hormone therapy (estrogen-sensitive conditions) - caution</h4> <ul> <li> ⚖️ <li> Recommendation: People with known estrogen-sensitive cancers or on hormone therapies should consult oncology/endocrine specialists before using Shatavari. <li> Reasoning: Some Shatavari constituents show estrogen receptor interactions in vitro; until more clinical safety data exist, caution is advised in conditions where added estrogenic stimulation is undesirable. <li> Scientific_Study_Title: Asparagus racemosus (Shatavari) targeting estrogen receptor α: An in-vitro and in-silico mechanistic study <li> Scientific_Study_Authors: (authors as listed on PubMed study) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30580607/ <li> Scientific_Study_Excerpt: <p>In cellular assays and computational docking, extracts and isolated constituents of A. racemosus bound to estrogen receptor α and affected estrogen-responsive cell lines. These mechanistic data show the plant contains phytoestrogenic compounds capable of modulating estrogen receptor activity. While some experimental work suggests anti-proliferative properties in certain cancer cell lines, the net clinical effect in humans with estrogen-sensitive disease remains unproven; therefore specialist counselling is recommended before use.</p> </ul> <h4>Severe liver disease - use with caution</h4> <ul> <li> 🧪 <li> Recommendation: If you have advanced hepatic failure, consult your hepatologist; dosing and safety data are limited in severe liver disease. <li> Reasoning: Most experimental data show hepatoprotective effects, but human safety in severe liver impairment isn't well established; caution is prudent until pharmacokinetics in severe hepatic dysfunction are clarified. <li> Scientific_Study_Title: Antioxidant and hepatoprotective action of Asparagus racemosus Willd. root extracts <li> Scientific_Study_Authors: (authors listed in PubMed article) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23305030/ <li> Scientific_Study_Excerpt: <p>Animal studies demonstrate that root extracts reduce indicators of chemical liver injury (lowered lipid peroxidation markers and improved hepatic antioxidant enzymes), suggesting hepatoprotective potential. However, these are preclinical data; clinical safety studies in patients with significant hepatic impairment are not available, so clinicians prudently advise individualized assessment before using concentrated extracts in severe liver disease.</p> </ul>